Michael X Repka, Katherine K Weise, Danielle L Chandler, Rui Wu, B Michele Melia, Ruth E Manny, Lori Ann F Kehler, Catherine O Jordan, Aparna Raghuram, Allison I Summers, Katherine A Lee, David B Petersen, S A Erzurum, Yi Pang, Phoebe D Lenhart, Benjamin H Ticho, Roy W Beck, Raymond T Kraker, Jonathan M Holmes, Susan A Cotter
IMPORTANCE: Controlling myopia progression is of interest worldwide. Low-dose atropine eye drops have slowed progression in children in East Asia. OBJECTIVE: To compare atropine, 0.01%, eye drops with placebo for slowing myopia progression in US children. DESIGN, SETTING, AND PARTICIPANTS: This was a randomized placebo-controlled, double-masked, clinical trial conducted from June 2018 to September 2022. Children aged 5 to 12 years were recruited from 12 community- and institution-based practices in the US...
July 13, 2023: JAMA Ophthalmology